The Technical Advisory Committees (TAC) for Safety was formed to act as a forum to advice the FDA Ghana on matters relating to the post-approval safety, quality, efficacy and effectiveness of products granted marketing authorization by the Authority. The TAC provides expertise to assist the FDA Ghana in making appropriate risk management decisions, however, the decision making responsibility remains with the FDA Ghana.
The mandate of the TAC is to provide the FDA Ghana with on-going and timely medical and scientific advice on current and emerging issues related to post-approval product surveillance based on spontaneous reports received from healthcare professionals and decisions taken by National Regulatory Authorities (NRAs) worldwide.
The TAC is made up of experts from eleven scientific backgrounds. The TAC may also co-opt expert(s) from other fields that are not amongst the core membership for specific issues.
The FDA exists to protect public health by assuring the safety, efficacy and security of human and veterinary drugs, food, biological products, cosmetics, medical devices, household chemical substances, tobacco and the conduct of clinical trials in the country.